Current through Register Vol. 48, No. 12, March 22, 2024
a) The
optimum starting ages for the specified immunizing procedures are as follows:
1) Diphtheria - two to four months
2) Pertussis - two to four months, combined
with tetanus toxoid
3) Tetanus -
two to four months
4) Poliomyelitis
- two to four months
5) Measles -
12 to 15 months
6) Rubella - 12 to
15 months
7) Mumps - 12 to 15
months
8) Haemophilus - two to four
months influenzae type b
9)
Hepatitis B - birth to two months
10) Varicella - 12 to 18 months
11) Invasive Pneumococcal Disease - two to
four months
12) Meningococcal
Disease - 11 to 12 years
b) Upon first entering a child care facility,
all children two months of age and older shall show proof that the child has
been immunized, or is in the process of being immunized, according to the
recommended schedule, against diphtheria, pertussis, tetanus, polio, measles,
mumps, rubella, Haemophilus influenzae type b, hepatitis B, varicella, and
invasive pneumococcal disease, unless proved to be immune as determined by
Sections
665.250 and
665.280,
parents object based on religious grounds in accordance with Section
665.510, or a
licensed physician, advanced practice nurse or physician assistant issues a
medical exemption in accordance with Section
665.520.
c) Diphtheria, Pertussis, Tetanus
1) Any child entering a child care facility
or school program below the kindergarten level shall show proof of having
received three or more doses of Diphtheria, Tetanus, Pertussis (DTP or DTaP)
vaccine by one year of age and one additional dose by the second birthday. The
first three doses in the series shall have been received no less than four
weeks (28 days) apart. The interval between the third and fourth doses shall be
at least six months.
2) Any child
entering school (kindergarten or first grade) for the first time shall show
proof of having received four or more doses of Diphtheria, Tetanus, Pertussis
(DTP or DTaP) vaccine, with the last dose being a booster and having been
received on or after the fourth birthday. The first three doses in the series
shall have been received no less than four weeks (28 days) apart. The interval
between the third and fourth doses shall be at least six months. Children age
six and under may receive DTaP or DTP. Children age seven and older may receive
Tetanus, Diphtheria (Td) vaccine as recommended pursuant to the ACIP catch-up
series in lieu of DTP or DTaP vaccine.
3) Any child entering school at a grade level
not included in subsection (c)(1) or (2) shall show proof of having received
three or more doses of DTP, DTaP, pediatric DT or adult Tetanus and Diphtheria
(Td), with the last dose being a booster and having been received on or after
the fourth birthday. The first two doses in the series shall have been received
no less than four weeks (28 days) apart. The interval between the second and
third doses shall be at least six months.
4) Receipt of pediatric Diphtheria Tetanus
(DT) vaccine in lieu of DTP or DTaP is acceptable only if the pertussis
component of the vaccine is medically contraindicated. Documentation of the
medical contraindication shall be verified as specified in Section
665.520.
5) Any child entering
sixth grade shall show proof of having received one dose of Tdap (defined as
tetanus, diphtheria, acellular pertussis) vaccine regardless of the interval
since the last DTaP, DT or Td dose.
6) Students entering grades seven through 12
who have not already received Tdap are required to receive one Tdap dose
regardless of the interval since the last DTaP, DT or Td dose.
7) For students attending school programs in
which grade levels (kindergarten through 12) are not assigned, including
special education programs, proof of one dose of Tdap vaccine as described in
subsection (c)(5) shall be submitted before the school years in which the child
reaches the ages of 11 and 15. Students eligible to remain in public school
beyond grade 12 (special education) shall meet the requirements for
12th grade.
8) School-age children entering a child care
facility shall comply with the immunization requirements of subsections (c)(2),
(3), (4), (5), (6) and (7).
d) Polio
1)
Any child entering a child care facility or school program below the
kindergarten level shall show proof of having received two or more doses of
polio vaccine (defined as oral poliovirus vaccine (OPV) or inactivated
poliovirus vaccine (IPV)) by one year of age and a third dose by the second
birthday. Doses in the series shall have been received no less than four weeks
(28 days) apart. Any child 24 months of age or older shall show proof of at
least three doses of polio vaccine appropriately spaced.
2) Any child entering school at any grade
level (kindergarten through 12) shall show proof of having received three or
more doses of polio vaccine (defined as oral poliovirus vaccine (OPV) or
inactivated poliovirus vaccine (IPV)). A child who received any combination of
IPV and OPV shall show proof of having received at least four doses, with the
last dose having been received on or after the fourth birthday. Doses in the
series shall have been received no less than four weeks (28 days) apart. A
child who received IPV exclusively or OPV exclusively shall show proof of
having received at least three doses, with the last dose having been received
on or after the fourth birthday. Doses in the series shall have been received
no less than four weeks (28 days) apart.
3) Beginning with the school year 2017-2018,
any child entering kindergarten shall show proof of having received four or
more doses of polio vaccine (defined as oral poliovirus vaccine (OPV) or
inactivated poliovirus vaccine (IPV)). The first three doses in the series
shall have been received no less than four weeks (28 days) apart. The fourth or
last dose shall be administered on or after the fourth birthday and at least
six months after the previous dose. A fourth dose is not needed if the third
dose was administered at age four or older and at least six months after the
previous dose, in accordance with the ACIP catch-up series.
4) For students attending school programs in
which grade levels (kindergarten through 12) are not assigned, including
special education programs, proof of polio vaccine shall be submitted before
the school years in which the child reaches the ages of five, 11 and 15.
Students eligible to remain in public schools beyond grade 12 (special
education) shall meet the requirements for 12th
grade.
5) School-age children
entering a child care facility shall comply with the immunization requirements
in subsection (d)(2).
e)
Measles
1) Any child entering a child care
facility or school program below the kindergarten level shall show proof of
having received one dose of live measles virus vaccine on or after the first
birthday, or other proof of immunity described in Section
665.250(c).
2) Children entering school at any grade
level (kindergarten through 12) shall show proof of having received two doses
of live measles virus vaccine, the first dose on or after the first birthday
and the second dose no less than four weeks (28 days) after the first or other
proof of immunity described in Section
665.250(c).
3) For students attending school programs
where grade levels (kindergarten through 12) are not assigned, including
special education programs, proof of two doses of live measles virus vaccine as
described in subsection (c)(2) shall be submitted before the school years in
which the child reaches the ages of five, 11 and 15. Students eligible to
remain in public schools beyond grade 12 (special education) shall meet the
requirements for 12th grade.
4) School-age children entering a child care
facility shall comply with the immunization requirements in subsections (e)(2)
and (3).
f) Rubella
1) Any child entering a child care facility
or school program below the kindergarten level shall show proof of having
received at least one dose of live rubella virus vaccine on or after the first
birthday. Proof of disease is not acceptable unless laboratory evidence of
rubella immunity is presented (see Section
665.250(d)
).
2) Children entering school at
any grade level (kindergarten through 12) shall show proof of having received
two doses of live rubella virus vaccine, the first dose on or after the first
birthday and the second dose no less than four weeks (28 days) after the first
dose, or other proof of immunity described in Section
665.250(c).
3) For students attending school programs
where grade levels (kindergarten through 12) are not assigned, including
special education programs, proof of two doses of live rubella virus vaccine as
described in subsection (f)(2) shall be submitted before the school years in
which the child reaches the ages of five, 11 and 15. Students eligible to
remain in public school beyond grade 12 (special education) shall meet the
requirements for 12th grade.
4) School-age children entering a child care
facility shall comply with the immunization requirements in subsections (f)(2)
and (3).
g) Mumps
1) Any child entering a child care facility
or school program below the kindergarten level shall show proof of having
received at least one dose of live mumps virus vaccine on or after the first
birthday. Proof of disease, if verified by a physician, or laboratory evidence
of mumps immunity may be substituted for proof of vaccination (see Section
665.250(e)
).
2) Children entering school at
any grade level (kindergarten through 12) shall show proof of having received
two doses of live mumps virus vaccine, the first dose on or after the first
birthday and the second dose no less than four weeks (28 days) after the first
dose, or other proof of immunity described in Section
665.250(c).
3) For students attending school programs
where grade levels (kindergarten through 12) are not assigned, including
special education programs, proof of having received two doses of live mumps
virus vaccine as described in subsection (e)(2) shall be submitted before the
school years in which the child reaches the ages of five, 11 and 15. Students
eligible to remain in public school beyond grade 12 (special education) shall
meet the requirements for 12th grade.
4) School-age children entering a child care
facility shall comply with the immunization requirements in subsections (g)(2)
and (3).
h) Haemophilus
influenzae type b (Hib)
1) Any child entering
a child care facility or school program below the kindergarten level shall show
proof of immunization that complies with the ACIP recommendation for Hib
vaccination.
2) Children 24 to 59
months of age who have not received the primary series of Hib vaccine,
according to the Hib vaccination schedule, shall show proof of receiving one
dose of Hib vaccine at 15 months of age or older.
3) Any child five years of age or older shall
not be required to provide proof of immunization with Hib vaccine.
i) Hepatitis B
1) Any child entering a child care facility
or school program below the kindergarten level shall show proof of having
received three doses of hepatitis B vaccine. The first two doses shall have
been received no less than four weeks (28 days) apart. The interval between the
second and third doses shall be at least two months. The interval between the
first dose and the third dose shall be at least four months. The third dose
shall have been administered on or after six months of age. Proof of prior or
current infection, if verified by laboratory evidence, may be substituted for
proof of vaccination (see Section
665.250(f)
).
2) Children entering the sixth
grade shall show proof of having received three doses of hepatitis B vaccine,
or other proof of immunity described in Section
665.250(f).
The first two doses shall have been received no less than four weeks (28 days)
apart. The interval between the second and third doses shall be at least two
months. The interval between the first and third doses shall be at least four
months. Proof of prior or current infection, if verified by laboratory
evidence, may be substituted for proof of vaccination (see Section
665.250(f)
).
3) The third dose of hepatitis B
vaccine is not required if it can be documented that the child received two
doses of adult formulation Recombivax-HB vaccine (10 mcg) and was 11 to 15
years of age at the time of vaccine administration, and that the interval
between receipt of the two doses was at least four months.
4) Proof of prior or current hepatitis B
infection shall be verified by laboratory evidence. Laboratory evidence of
prior or current hepatitis B infection is acceptable only if one of the
following serologic tests indicates positivity: HBsAg, anti-HBc or
anti-HBs.
5) For students attending
school programs for which grade levels (kindergarten through 12) are not
assigned, proof of having received three doses of hepatitis B vaccine or other
proof of immunity as described in subsections (i)(2), (3) and (4) shall be
submitted before the school years in which the child reaches the ages of 11 and
15. Students eligible to remain in public school beyond grade 12 (special
education) shall meet the requirements for 12th
grade.
6) School-age children
entering a child care facility shall comply with the immunization requirements
in subsections (i)(2) and (3).
j) Varicella
1) Any child entering a child care facility
or school program below the kindergarten level shall show proof of having
received one dose of varicella vaccine on or after the first birthday, or other
proof of immunity described in Section
665.250(g).
2) Children entering school at any grade
level (kindergarten through 12) shall show proof of having received at least
one dose of varicella vaccine on or after the first birthday, or other proof of
immunity described in Section
665.250(g).
3) Any child entering kindergarten, sixth
grade, or ninth grade for the first time on or after July 1, 2014 shall show
proof of having received two doses of varicella vaccine, the first dose on or
after the first birthday and the second dose no less than four weeks (28 days)
after the first dose, or other proof of immunity described in Section
665.250(g).
4) For students attending school programs
where grade levels (kindergarten through 12) are not assigned, proof of having
received at least two doses of varicella vaccine in accordance with subsection
(j)(2) or (3) or other proof of immunity as described in Section
665.250(g)
shall be submitted prior to the school years in which the child reaches the
ages of five, 11 and 15. Students eligible to remain in public school beyond
grade 12 (special education) shall meet the requirements for
12th grade.
5) School-age children entering a child care
facility shall comply with the immunization requirements in subsections (j)(2)
and (3).
k) Invasive
Pneumococcal Disease
1) Any child entering a
child care facility or school program below the kindergarten level shall show
proof of immunization that complies with the ACIP recommendations for
pneumococcal vaccination.
2)
Children 24 to 59 months of age who have not received the primary series of
pneumococcal conjugate vaccine, according to the recommended vaccination
schedule, shall show proof of receiving one dose of pneumococcal vaccine after
24 months of age.
3) Any child who
has reached his or her fifth birthday shall not be required to provide proof of
immunization with pneumococcal conjugate vaccine.
l) Meningococcal Disease
1) Beginning with the school year 2015-2016,
any child entering the sixth grade shall show proof of having received one dose
of meningococcal conjugate vaccine on or after the
11th birthday. Children who do not meet the age
requirement will be monitored in accordance with Section
665.270.
2) Beginning with the school year 2015-2016,
any child entering the 12th grade shall show proof
of having received two doses of meningococcal conjugate vaccine prior to
entering the 12th grade. The first dose shall have
been received on or after the 11th birthday, and the
second dose shall have been received on or after the
16th birthday, at least eight weeks after the first
dose. If the first dose is administered when the child is 16 years of age or
older, only one dose is required.
3) For students attending school programs
where grade levels (kindergarten through 12) are not assigned, including
special education programs, proof of having received one dose of meningococcal
conjugate vaccine shall be submitted in the school year in which the child
reaches age 11 and a second dose in the school year in which the child reaches
age 16. If the first dose is administered when the child is 16 years of age or
older, only one dose is required. Students eligible to remain in public school
beyond grade 12 (special education) shall meet the requirements for
12th grade.
m) The requirements of this Section also
apply to children who transfer into Illinois child care facilities, school
programs, and schools from other states, regardless of the age or grade level
at which the child transfers.
n) It
is not the intent of this Part that any child whose parents comply with the
intent of this Part, the Act or the School Code should be excluded from a child
care facility or school. A child or student shall be considered in compliance
with the law if there is evidence of the intent to comply. Evidence may be:
1) a signed statement from a health care
provider that he or she has begun, or will begin, the necessary immunization
procedures; or
2) the parent's or
legal guardian's written consent for the child's participation in a school or
other community immunization program.